Business Description
Viemed Healthcare Inc
NAICS : 334510
SIC : 3359
ISIN : CA92663R1055
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.56 | |||||
Equity-to-Asset | 0.74 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.18 | |||||
Interest Coverage | 18.31 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 6.73 | |||||
Beneish M-Score | -2.78 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 11.8 | |||||
3-Year EBITDA Growth Rate | 0.3 | |||||
3-Year EPS without NRI Growth Rate | -29.3 | |||||
3-Year FCF Growth Rate | -4.6 | |||||
3-Year Book Growth Rate | 12.4 | |||||
Future 3-5Y EPS without NRI Growth Rate | 27.28 | |||||
Future 3-5Y Total Revenue Growth Rate | 15.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -15.34 | |||||
12-1 Month Momentum % | 4.87 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.31 | |||||
Quick Ratio | 1.19 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 19.19 | |||||
Days Sales Outstanding | 39.16 | |||||
Days Payable | 39.29 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.6 | |||||
Shareholder Yield % | -0.55 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 60.28 | |||||
Operating Margin % | 7.56 | |||||
Net Margin % | 4.87 | |||||
FCF Margin % | 1.62 | |||||
ROE % | 8.94 | |||||
ROA % | 6.58 | |||||
ROIC % | 8.83 | |||||
ROC (Joel Greenblatt) % | 20.87 | |||||
ROCE % | 13 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 30.77 | |||||
Forward PE Ratio | 22.71 | |||||
PE Ratio without NRI | 31.75 | |||||
Price-to-Owner-Earnings | 22.04 | |||||
PEG Ratio | 1.74 | |||||
PS Ratio | 1.51 | |||||
PB Ratio | 2.49 | |||||
Price-to-Tangible-Book | 3.42 | |||||
Price-to-Free-Cash-Flow | 90.91 | |||||
Price-to-Operating-Cash-Flow | 8.68 | |||||
EV-to-EBIT | 18.45 | |||||
EV-to-EBITDA | 7.32 | |||||
EV-to-Revenue | 1.41 | |||||
EV-to-Forward-Revenue | 1.34 | |||||
EV-to-FCF | 86.17 | |||||
Price-to-Projected-FCF | 1.32 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.29 | |||||
Price-to-Net-Current-Asset-Value | 104.5 | |||||
Earnings Yield (Greenblatt) % | 5.42 | |||||
FCF Yield % | 1.13 | |||||
Forward Rate of Return (Yacktman) % | 17.08 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Viemed Healthcare Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | 290.456 | ||
EPS (TTM) (C$) | 0 | ||
Beta | 0 | ||
Volatility % | 39.28 | ||
14-Day RSI | 0 | ||
14-Day ATR (C$) | 0.511429 | ||
20-Day SMA (C$) | 0 | ||
12-1 Month Momentum % | 4.87 | ||
52-Week Range (C$) | 8.14 - 16.25 | ||
Shares Outstanding (Mil) | 38.49 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Viemed Healthcare Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Viemed Healthcare Inc Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Viemed Healthcare Inc Frequently Asked Questions
What is Viemed Healthcare Inc(TSX:VMD)'s stock price today?
When is next earnings date of Viemed Healthcare Inc(TSX:VMD)?
Does Viemed Healthcare Inc(TSX:VMD) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |